Understanding epilepsy, one of the most frequent chronic neurological conditions, requires recognizing it as a spectrum of brain disorders characterized by a persistent tendency to generate seizures. In the 20th century, researchers like James Kiffin Penry advanced the development and clinical testing of antiseizure medications, improving treatment options and patient outcomes. Dr. Penry helped shape modern standards for epilepsy treatment, expanded therapeutic options, strengthened collaboration between researchers and advocacy organizations, and contributed to better outcomes and quality of life for people with epilepsy worldwide. A systematic search of published articles was conducted using PubMed and Google Scholar to chronicle Penry's personal and professional life. We focus on James Kiffin Penry's contributions to epilepsy research, his advocacy for standardizing diagnostic criteria for epilepsy, and his pivotal role in advancing regulatory approval of carbamazepine and valproic acid, key antiseizure medications. We conclude with Penry's posthumous contributions to epilepsy education through the J. Kiffin Penry Epilepsy Fellow Network, held annually in his hometown of Winston-Salem, North Carolina. The contributions of Dr. James Penry earned him recognition as a leader in the field of modern epilepsy.
Wei et al. (Fri,) studied this question.